Marketing-authorisation holder
+pharma arzneimittel gmbh
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Sacubitril/Valsartan Pluspharma 24 mg/26 mg filmomhulde tablettenFilmomhulde tablet | Sacubitril, Valsartan | Netherlands | Authorised | 2025 |
| Sacubitril/Valsartan Pluspharma 49 mg/51 mg filmomhulde tablettenFilmomhulde tablet | Sacubitril, Valsartan | Netherlands | Authorised | 2025 |
| Sacubitril/Valsartan Pluspharma 97 mg/103 mg filmomhulde tablettenFilmomhulde tablet | Sacubitril, Valsartan | Netherlands | Authorised | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09D
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- pharma arzneimittel
- pharma arzneimittel gmbh
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder